A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines
Public ClinicalTrials.gov record NCT00076063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC Prime/LIPO-5 Boost in Healthy, HIV-1 Uninfected Adult Participants
Study identification
- NCT ID
- NCT00076063
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 174 participants
Conditions and interventions
Conditions
Interventions
- ALVAC-HIV (vCP1452) Biological
- LIPO-5 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2004
- Primary completion
- Not listed
- Completion
- Feb 28, 2007
- Last update posted
- Oct 13, 2021
2004 – 2007
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Vaccine CRS | Birmingham | Alabama | 35294-2041 | — |
| Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore | Baltimore | Maryland | — | — |
| Project Brave HIV Vaccine CRS | Baltimore | Maryland | — | — |
| Brigham and Women's Hosp. CRS | Boston | Massachusetts | 02115 | — |
| Fenway Community Health Clinical Research Site (FCHCRS) | Boston | Massachusetts | 02215 | — |
| Saint Louis Univ. School of Medicine, HVTU | St Louis | Missouri | — | — |
| Univ. of Rochester HVTN CRS | Rochester | New York | 14642-0001 | — |
| NY Blood Ctr./Bronx CRS | The Bronx | New York | 10456 | — |
| Miriam Hospital's HVTU | Providence | Rhode Island | 02906 | — |
| Vanderbilt Vaccine CRS | Nashville | Tennessee | 37232 | — |
| FHCRC/UW Vaccine CRS | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00076063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2021 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00076063 live on ClinicalTrials.gov.